Compositions and methods of use for tyrosine kinase inhibitors to treat pathogenic infection

Details for Australian Patent Application No. 2005209231 (hide)

International Classifications

Event Publications

17 August 2006 PCT application entered the National Phase

PCT publication WO2005/072826 Priority application(s): WO2005/072826

17 August 2006 Change of Name(s) of Applicant(s), Section 104

Emory University The name of the applicant has been changed to Emory University; Memorial Sloan Kettering Cancer Center

31 August 2006 Change of Name(s) of Applicant(s), Section 104

Emory University; Memorial Sloan-Kettering Institute Cancer Centre. The name of the applicant has been changed to Emory University; Sloan-Kettering Institute for Cancer Research.

17 March 2011 Application Accepted

Published as AU-B-2005209231

14 July 2011 Standard Patent Sealed

28 July 2011 Corrigenda

Applications Accepted - Name Index Under the name Sloan-Kettering Institute for Cancer Research.; Emory University, Application No. 2005209231, under INID (71) correct the co-applicant name to Sloan-Kettering Institute for Cancer Research

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.